SEC Form 4 · accession 0001209191-18-002199
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Immanuel Thangaraj
Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 6:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Jan 2, 2018 | M | 35,714 | — | A | 59,526 | D | |
| Common StockF4 | holding | — | — | — | 1,956,396 | I | By Essex Woodlands Health Ventures Fund V, L.P |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF7,F2,F5,F6 | — | Jan 2, 2018 | M | 35,714 | A | — | — | Common Stock | 35,714 | 23,809 | D |
| Restricted Stock UnitsF2,F5,F6 | — | Jan 2, 2018 | D | 23,809 | D | — | — | Common Stock | 23,809 | 0 | D |
| Restricted Stock UnitsF7,F2,F5,F8 | — | Jan 2, 2018 | A | 66,666 | A | — | — | Common Stock | 66,666 | 66,666 | D |
Explanation of responses
- F1Represents exchange of restricted stock units.
- F2Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- F3Does not include Restricted Stock Units.
- F4The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F51 - for -1
- F659,523 Restricted Stock Units were granted on the first business day of January 2017. 25% of such Restricted Stock Units vested on March 31, 2017, 25% vested on June 30, 2017; 25% vested on September 30, 2017 and 25% vested on December 31, 2017. 40% of such Restricted Stock Units are being settled in cash and 60% are being settled in stock, in each case upon payment of par value.
- F7N/A
- F825% of Restricted Stock Units vest on the last day of each of March, June, September and December 2018, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2019, or earlier upon a change of control.